RECOMBINANT POLYCLONAL PROTEINS TARGETING HEPATITIS B VIRUS (HBV) AND METHODS OF USE THEREOF

Fecha de publicación: --
Fuente: WIPO "tomato"
Provided herein are pharmaceutical compositions comprising recombinant polyclonal antibodies for treatment of hepatitis B. Specifically, recombinant polyclonal antibodies specific to HBV antigens are provided. Also provided are the methods of making a pharmaceutical composition comprising the recombinant polyclonal antibodies.